Ligand profile
AOB
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0984 — hypothetical protein
Identifiers
Database identifiers and provenance.
- Ligand ID
AOB- PDB
4cm6- UniProt (similar protein)
O76290- Target protein
- VK055_0984
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 111.3
- −1 ≤ LogP ≤ 5 1.88
- MW ≤ 500 Da 277.3
- LogP ≤ 5 1.88
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 111.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(cc1)C=Cc2c(c3c([nH]2)N=C(NC3=O)N)C#Nc1ccc(cc1)C=Cc2c(c3c([nH]2)N=C(NC3=O)N)C#N
InChI=1S/C15H11N5O/c16-8-10-11(7-6-9-4-2-1-3-5-9)18-13-12(10)14(21)20-15(17)19-13/h1-7H,(H4,17,18,19,20,21)InChI=1S/C15H11N5O/c16-8-10-11(7-6-9-4-2-1-3-5-9)18-13-12(10)14(21)20-15(17)19-13/h1-7H,(H4,17,18,19,20,21)
WPTUPLITBGLORN-UHFFFAOYSA-NWPTUPLITBGLORN-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand AOB →
- PDB RCSB structure 4cm6 →
- UniProt UniProt O76290 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “AOB”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0984.
PDB 92
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 35
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).